Dear Reader,
He's a big bear of a man.
But there wasn’t a dry eye in the house when a famous TV anchorman, “Barry,” tearfully revealed his story as a cancer survivor.
Barry was diagnosed with very aggressive cancer of the neck and spine at the age of 50.
Now he regards himself as the “luckiest guy on Earth."
These days, the proud father of young twins is sending a stark warning to the world...
A toxin found in virtually every diet, including his own, feeds cancer cells!
“There’s an immediate change in your body when you cut the toxin,” says Barry. “I’m talking about deep down benefits at a cellular level.”
Dr. Robert Lustig, a pediatric endocrinologist at the University of California-San Francisco, says...
“Our brain lights up from this toxin the same way it does for cocaine.” – Dr. Robert Lustig
But when this dangerous toxin is removed, well... miracles are already happening.
“My cholesterol went from 268 to 184 and my triglycerides from 271 to 75. I’m simply amazed! My cholesterol and triglycerides have never been that low as far back as my records show which is 1998.” – Marc Pippen
“I’m now off blood pressure medication, I’ve ‘cured’ my own depression and off meds as well, not to mention a myriad of other benefits.” – Jeff Lewis
“My father-in-law has diabetes... there’s no way the family would’ve survived without it.” – Eric Harris
“I have an autoimmune disease that attacks the thyroid... it started as an experiment, but my energy, skin and wellness changed so dramatically, I kept going.” – Samantha Wilson
“I had swollen fingers (especially my thumbs) that I was unable to bend for hours after awakening. Medications, wristbands, and anti-Inflammatory drugs did no good. But this cured my arthritis!” – Rebecca Kimes
Contamination Levels Have TRIPLED in the Last 50 years...
Imagine spilling syrup on your keyboard.
Well, now you have a visual of what occurs inside a human cell when this toxic additive takes full effect.
The toxin gums up our body by changing its metabolism.
It raises blood pressure.
It critically alters the signaling of hormones.
It catastrophically damages the pancreas and liver, too.
But the worst part?
Until now... it’s been virtually IMPOSSIBLE to remove this toxin from our diet.
So here we are... for the first time in human history, non-communicable diseases pose a greater health threat than infectious diseases.
Heart disease, cancer and diabetes now contribute to 35 million deaths annually.
A whopping 75% of all U.S. healthcare dollars are spent treating these diseases... and EVERY PENNY can be traced back to this deadly food additive.
According to a Credit Suisse report, this toxin places a $1 trillion-per-year burden on the U.S. healthcare system.
Such a reality is unsustainable.
And now, Medicare sits on the brink of collapse. (See infobox: Congress’ Dirty Little Medicare Secret.)
But healthcare’s savior is finally here...
Patent #20110X858867 could mark the end of the world’s most dreaded diseases... including the big ones like cancer, heart disease and diabetes.
But are you prepared for the downstream financial effects? They’re poised to rewrite stock market history. In fact, they could put between $79,840 and $141,410 into your trading account, beginning with your first 100% gain in the next few days.
Introducing the Most Valuable Patent in History...
It’s ready to replace the patent on Lipitor as the most valuable in history.
Lipitor generated $108 billion in revenue over 20 years, and helped drive Pfizer from a penny stock to one of the most powerful companies in the S&P 500.
But Lipitor ONLY manages cholesterol levels.
These miracle crystals attack the root cause of virtually every non-communicable disease on the planet.
Andrew Hattesburg attacked the root cause of his Diabetes...
“I’ve been diagnosed as having Type 2 Diabetes, and this helps me keep my blood levels on an even keel and is helping with weight loss.”
Janet Atwater’s body chemistry changed for the better, too...
“My skin, eyes, hair, EVERYTHING is healthy and radiant! I have so much energy and I’ve lost weight. I haven’t felt this good since I was 17.”
For Stephen Battaglia, it was arthritis...
“After being told I had rheumatoid arthritis, and gobbling anti-inflammatory medication on a daily basis, I decided to try it. The medication has become a thing of the past!”
With such promise comes what could be the largest valuation ever bestowed upon a single patent...
I estimate the patent’s low end to be worth $70 billion.
But its upside runs as high as $134 billion.
I know, I know... $70 billion is a massive figure.
So allow me to put it in perspective for you.
This patent alone is worth more than the combined revenue of all four major U.S. sports leagues – NFL, MLB, NHL, and NBA.
It’s worth more than last year’s combined revenue of the top 50 grossing films.
And it’s worth roughly the same amount as the global tablet industry, including all iPad sales.
The best part for investors?
One company trading for less than $10/share owns the exclusive rights to the patent.
Extracting Miracle Crystals from a Leaf...
The crystals hide deep inside the leaves of a plant native to South America.
Indigenous tribes have been enjoying the medicinal properties of the leaves for more than 1,500 years.
But science has NEVER been able to extract only the miracle crystals from the leaf.
That is, until now.
I’m happy to report that a certain company just cracked the plant’s genetic code, and a patent now safeguards the secret.
The active compound found inside the leaf, called “RUBY-A,” attacks the root cause of virtually every non-communicable disease on Earth.
Exactly how powerful are these RUBY-A crystals?
Enough that the FDA gave its blessing to begin adding the crystals to the food supply, immediately.
RUBY-A is a natural, organic replacement for the toxic food additive found in every North American diet.
Before a drug can be mass marketed, it must pass a series of THREE rigorous FDA clinical trials, called phases.
That is, unless it receives special permission by the FDA to bypass the approval phases entirely. “Phase Zero,” if you will.
Phase 1: Researchers test a new drug on a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
“Phase 0”: In RUBY-A’s case, after extensive scientific procedures, it was cleared for commercialization without needing any further FDA approvals.
(The toxin enhances the flavor of processed foods.)
You’ll recall that when I mixed the powdery RUBY-A into a glass of water and drank it, I accomplished something extraordinary...
I preempted the onset of cancer, obesity, diabetes, heart disease, hypertension, high cholesterol, Alzheimer’s disease, kidney disease, arthritis and depression.
I’m not alone, either.
Nick Makres attacked the root cause of his depression and joint pain...
“I no longer have anger issues, depression/mood swings, joint pain. I can’t believe something so ‘simple’ made such a difference in my life!”
For Sarah Hoy, it was cancer...
“After undergoing rigorous cancer treatments, I revitalized my health. I’ve been able to enjoy being cancer free again, I’ve relished watching my daughter turn into a chatterbox.”
For Albert Saunders, it was Grave’s disease....
“It helped my autoimmune disease (Graves’ disease). I was originally on 12 tablets a day and now I’m down to two, working towards none!”
FDA Grants RUBY-A Special Exemption...
Only five in 5,000 drugs that enter the FDA’s rigorous preclinical testing ever make it into human testing.
Of these five drugs, only one is ultimately approved by the FDA for commercialization.
So the chance of a new drug actually making it to market is only one in 5,000.
Not very good odds, huh?
But catch a ride on a company cruising through the FDA’s three phases of testing and, well... riches await such an investor. The stakes get higher with every phase of FDA approval, too.
Consider, in 2014 alone...
Avanti Pharmaceuticals (AVNR) raced 427% higher thanks to the ongoing development of its migraine drug, AVP-825.
If approved, AVP-825 would be the first fast-acting, nasal mist for the treatment of migraine headaches in which 13 million Americans suffer from.
The migraine market is worth $3.3 billion.
AVP-825 is presently in Phase 3 of FDA testing.
Now, I’m sure AVP-825 is a fine drug. But RUBY-A is proven to attack the root cause of migraines, preempting their onset.
Agios Pharmaceuticals (AGIO) shot 376% higher on the advancement of its cancer drug, AG-221.
Sadly, another 1.6 million people will be diagnosed with cancer this year, but AG-221 is showing real promise in fighting the most aggressive tumors.
Cancer is a $216 billion-a-year industry.
AG-221 is presently in Phase 1 of FDA testing.
For the sake of everyone (including my parents who are both cancer survivors), I pray that AG-221 is able to eradicate tumors one day soon.
But RUBY-A is proven to attack the root cause of cancer, preempting its onset.
So which is more likely to put $141,410 in your pocket...? AG-221 or RUBY-A?
TG Therapeutics (TGTX) blasted 284% higher as its drug, ublituximab, continues to successfully navigate the FDA gauntlet.
The drug treats Chronic Lymphocytic Leukemia, a rare condition that attacks bone marrow.
The leukemia therapeutics market is worth $4 billion.
Ublituximab is presently in Phase 3 of FDA testing.
RUBY-A, however, attacks the root cause of leukemia before it even manifests, and the FDA has already given its blessing.
FDA Drug Approval Mints Overnight Billionaire...
I want you to consider what happened to Puma Biotechnology (PBYI) last summer.
Why? Because I believe it’s important to weigh its fate against the power of RUBY-A.
Puma Biotechnology’s drug, neratinib, earned Phase 3 FDA approval for the treatment of breast cancer in July.
Overnight, the stock blasted 295% higher.
The moonshot made Alan Auerbach, who owns 20% of the outstanding shares, an instant billionaire.
Auerbach's stake is worth over $1.3 billion.
Neratinib improves the survival rate in women with early-stage breast cancer by 33% compared to a placebo.
Now, if FDA drug approval can shoot shares of Puma Biotechnology 295% higher... that is, despite only 33% of women with breast cancer responding to treatment...
How high will the company that I’m tracking go?
Its “miracle crystals” could mark the end of cancer altogether, and they benefit 100% of the population, too.
You’ll recall the TV anchorman and cancer survivor, Barry said, “I’m talking about deep down benefits at a cellular level.”
Consider that RUBY-A also disrupts the onset of diabetes. Hypertension. Alzheimer's. Depression. Obesity. Migraines. Leukemia. Kidney disease. Arthritis... and heart disease.
The FDA’s RUBY-A directive is perfectly aligned with virtually every powerful health institution, as well. It’s a “who’s who” list that includes the American Heart Association, The Cancer Society of America and the world-renowned Johns Hopkins University.
Heck, even hospitals have started giving samples of RUBY-A to outgoing patients.
Cracking the $100 Milestone...
How fast can this $8 stock crack the $100 milestone?
Well, according to 60 Minutes, every year, Americans consume 130 pounds of the toxic food additive I’ve been telling you about.
Such excess equates to a third of a pound every day.
The toxin is so prevalent in our food supply that it requires a $70 BILLION industrial machine just to sustain our appetites.
Heck, you might not even realize how much you’re consuming!
Yet this toxin CAN’T simply be eliminated from our diets without a viable alternative. That is, because the toxin’s impact on the commercial appeal of processed foods is too vast.
Enter RUBY-A.
Remember when I ingested a glassful of it? Well, my body didn’t metabolize any of the active compounds as it would with a typical pharmaceutical drug.
It simply passed through my body without any adverse effects or buildup in the bloodstream, and stemmed the tide of every downstream metabolic disease.
RUBY-A’s clinical data was shockingly compelling, too. Enough that the FDA granted it immediate approval to replace the deadly toxin.
And now, with the FDA’s blessing and an airtight patent, the fully realized market value of RUBY-A is $70 billion.
Once the patent holder conquers a meager 1.6% of the market, which is virtually assured in the coming weeks, shares could jump as high as $113.
Sales are already growing at a furious pace, too, which means you could be $141,410 richer before the first day of spring.
Centers for Disease Control
World Health Organization
National Institutes of Health
The Mayo Clinic
American Heart Association
Cancer Treatment Centers of America
American Cancer Society
National Center for Biotechnology Information
The Arthritis Foundation
WebMD
The Obesity Society
American Diabetes Association
Psychology Today
National Institute of Mental Health
Johns Hopkins University
Harvard University
Alzheimer’s Association
Stanford University
Duke University
University of Pennsylvania
The Time to Strike is Now...
After more than 200 government-sponsored efficacy and safety studies, each yielding definitive results, RUBY-A was recently market tested in certain health-crisis “hot spots” across the Deep South.
The test now ranks among the greatest successes in U.S. history.
USA Today reports it was a smash hit, saying...
"We haven't seen a product hitting on all cycles like this for years." – USA Today
In fact, news that certain retailers were carrying a first-generation product containing RUBY-A triggered a frenzy.
One Florida location was selling 50 cases per week. And several store managers said customers were calling the store, asking managers to put some aside for them.
"I've done thousands of these product rollouts in my career and it's very uncommon for consumers to call a store and request that a product be put aside." – Elizabeth Haynes, President of market research firm Haynes & Co.
And now, an iconic American food brand – worth $185 billion – just changed its formula to include RUBY-A.
Its product is consumed at the rate of more than 1.8 billion units per day.
As you read this report, the reformulated product is flying off store shelves.
It’s part of a national product rollout to 322 million Americans, the largest rollout of the last 150 years.
Gains Shoot Dramatically Higher Whenever the Brain is Involved...
In a study aired on 60 Minutes, the symptoms of heart disease began to manifest in test subjects within two weeks of ingesting the deadly food toxin.
But the brain? Well, the impacts are triggered within milliseconds! Hence the government’s decision to grant RUBY-A approval for immediate use.
Remember the pediatric endocrinologist from the University of California-San Francisco, Dr. Robert Lustig?
He said, “Our brain lights up from this toxin the same way it does for cocaine.”
Well, 60 Minutes reporter, Sanjay Gupta, proved it with an MRI scan of his brain.
Gupta was administered a tiny dosage of the toxin.
The moment it hit his tongue, the scanner detected increased blood rushing to certain regions of his brain.
The image below shows the yellow regions lighting up with dopamine, just as the brain would with alcohol or drugs.
Here’s the really scary part...
Research has irrefutably proven that, over time, the toxin damages our brains in the exact same fashion as a heroin or cocaine addiction would.
This is a serious health crisis, folks!
No wonder Medicare could go bankrupt any second. (See infobox: Congress’ Dirty Little Medicare Secret.)
But when the toxin is eradicated, full health is restored.
“I developed a severe depression that forced me to stay in a clinic for two months. After about seven weeks, now I jump out of bed every morning to go for a walk, do some yoga or meditate.” – Derrick Mason
“It was an absolute revelation to me... being alert ALL day without an afternoon slump, and losing the brain fog.” – Leonard Zodda
“I’m a former fat girl who went from 170 pounds in my teens to now 115 pounds at 47-years-old. I look and feel better than I ever have in my life. I can do 30-plus pushups and vigorous cardio.” – Danielle Katz
When this deadly food toxin is ingested, within seconds, it raises blood pressure... triggers dangerous glucose levels... damages the body’s lipids, proteins and DNA... and hits the brain with a powerful dopamine blast.
The downstream metabolic effects kill 36 million people every year.
So this has the real potential to bring down Medicare.
It’s no joke!
Although largely unreported by the press, Congress has voted to pass a Medicare “accounting gimmick” for the last 12 years to keep the program solvent.
I’ll spare you the details.... but the gimmick, in effect, defers billions upon billions of dollars in Medicare payments to participating doctors.
Odds are that Congress will pass the gimmick again this year, just in time to keep Medicare running for a few more months.
Medicare’s Trustees are banking on it happening, too, having budgeted Congress’ trick into their latest Annual Report.
Meanwhile, 49 million Americans are relying upon a program that functions like a Congressional Ponzi scheme.
Will 2015 be the year that Medicare comes crashing down?
Well, on page 277 of that same Annual Report, Medicare’s own actuary, Richard Foster, concedes that Medicare’s bankruptcy could be just around the corner.
“The financial projections shown in this report for Medicare do not represent a reasonable expectation for actual program operations in either the short range... or the long range.” – Medicare actuary, Richard Foster.
Forbes magazine warns that the program’s bankruptcy will occur NEXT YEAR... that is, if Congress passes its trickery for the seventeenth time since 2003.
I encourage you to verify all of this with your Congressman or Google it.
It’s called Congress’ “doc fix.”
Now, perhaps I’m giving policymakers the benefit of the doubt here. But I believe they’ve been banking on the official arrival of Patent # 20110X858867 to single handedly save the healthcare system from collapse.
Why are Tobacco Farmers Killing Their Crops (on purpose)?
It’s simple, really. Money!
When researchers cracked the genetic code of the RUBY-A-bearing plant, it hatched an opportunity for farmers to earn limitless profits.
Especially tobacco farmers.
Despite the highly lucrative nature of tobacco, who could resist a much bigger payday?
According to Bloomberg, since the two leafs are handled similarly, the incredible demand for RUBY-A has farmers rushing to switch over their production.
Turns out, the RUBY-A-bearing plant and tobacco have a lot in common.
They grow in a similar climate and soils.
Both leaves are picked, separated from their stems and dried for use.
So farmers can use existing tobacco planters, harvesters, drying barns and loaders for their operation.
It makes perfect sense, financially speaking.
Oh, and the RUBY-A-bearing plant uses no pesticide, unlike tobacco, which means higher profit margins.
Farmers in warm states, like California, Georgia and North Carolina, are frantically making the switch as you read this.
I applaud them for thumbing their nose at tobacco... and re-positioning themselves toward a booming $70-billion industry.
Now, it’s your turn.
Be warned, however. The first push higher will likely be the most aggressive. It always is.
Yes, Making Money CAN be This Easy...
Warren Buffet once famously said...
“I always knew I’d be rich. I don't think I ever doubted it for a minute.” – Warren Buffett
He uttered those legendary words because, yes... making money is sometimes this easy.
As I see it, RUBY-A will disrupt the market in eight ways...
Disruptive Force #1:
RUBY-A attacks the root cause of every non-communicable disease on Earth, including cancer, obesity, diabetes, heart disease, hypertension, high cholesterol. It even attacks Alzheimer’s, kidney disease, arthritis and depression.
Disruptive Force #2:
A certain company’s patent guards the $70 billion market for RUBY-A. The patent could soon surpass Lipitor as the most valuable in history. Lipitor turned penny stock, Pfizer, into one of the most powerful companies in the S&P 500.
Disruptive Force #3:
The FDA sanctioned the approval of human trials in the Deep South, clearing the way for emergency use. By FDA mandate, you won’t need a prescription for RUBY-A. It’s perfectly safe as a food additive.
Disruptive Force #4:
RUBY-A’s miracle crystals just started hitting the food supply by way of a monster deal with an iconic U.S. food consortium.
Disruptive Force #5:
The national rollout just commenced, and it’s the largest in recorded history. Early data speaks to a smashing success. Half of store managers have reported being completely sold out. According to USA Today, people were asking store managers to “put the product aside for them.”
Disruptive Force #6:
To call RUBY-A a miracle is an understatement, as real-life success stories are already pouring in...
“During my uncle's four-month [cancer] cure period, he also lost 62 pounds of fat and flab, and Type 2 diabetes no longer registered.” – Dennis Sherman
“I’m off all my autoimmune disease medications. And today, I found out that I’m expecting. I’m only a few weeks along, so I can’t share with everyone yet. But after a year-long emotional journey, my body has been restored back to health.” – Kristin O’Donnell
Disruptive Force #7:
A powerful, multi-billion-dollar agribusiness is quietly amassing shares, led by a man named “Entrepreneur of the Year” and “Best CEO of the Year” by Ernst & Young. His company owns 18% of the patent holder’s shares. He could easily be the world’s latest billionaire when the first financial report hits.
Disruptive Force #8:
To date, the patent holder hasn’t filed a single financial report concerning the monster deal with a major U.S. food consortium. Such a reality has kept this opportunity hidden from most novice investors. But the first financial report is only a few weeks away. Expect it to blow the lid off of RUBY-A.
All the details can be found in my brand-new Special Report, including how RUBY-A could make you $141,410 richer... beginning with the release of its first financial report.
Here’s how to secure my brand-new report for FREE.
Allow me to introduce myself...
I’m Robert Williams, the Founder and power behind the highly-regarded financial publication, Wall Street Daily.
Now, unfortunately, since you’re reading this on the internet, you’re not in a position to reciprocate and introduce yourself to me.
But I feel that I can make some broad assumptions about you.
These assumptions are based on certain personality traits that I find in virtually all of my readers...
- Although you’ve done pretty well for yourself, you’re beginning to have doubts about your “dream retirement.”
- You’ve worked a lot harder than you ever wanted to in life.
- Your blood, sweat and tears should’ve lead to greater financial freedoms by now.
- You look at yourself and say, “I’m supposed to be happier than this.”
- Your life results don’t reflect your true self.
If you’re having any of these thoughts, don’t worry. They once struck a nerve with me, too.
These days, however, things are very different.
I can’t remember the last time I awakened to an alarm clock.
I don’t have a boss.
I ride public transportation to my office, yet I drive a white Porsche for fun.
I favor inexpensive sunglasses, yet my waterfront home is located on some of the most coveted property in the Mid-Atlantic.
I’m a normal guy living a very abnormal life.
How’d I do it?
Well, I’ve been fortunate enough to work alongside a certain kind of person... the type of person that you usually only read about or see on TV.
These folks are what I like to refer to as “True Alphas.”
I’ve worked alongside two self-made billionaires, both of whom own major American sports franchises... countless other self-made millionaires, including some of the most famous hedge fund managers in the world... and no less than 10 bestselling financial authors.
Along the way, I learned and adopted their secrets of living... I’ve since become a True Alpha myself.
And now, I enjoy sharing these secrets in Wall Street Daily’s flagship publication.
It’s called Robert Williams’ True Alpha.
Welcome to the Cutthroat World
of Hedge Funds...
There happens to be a hedge-fund term that perfectly captures the spirit of the research I publish.
It's referred to as "alpha."
In financial lingo, alpha is defined as the abnormal rate of return on a stock in excess of the benchmark index (i.e. – S&P 500).
The mathematical expression of alpha looks like this...
I realize that may look confusing, but it really isn’t.
A positive alpha of 1.0 simply implies that a stock has outperformed the benchmark index by 1%.
So a portfolio with an alpha score of 125 would look like this...
As you can easily see, those who consistently achieve high alphas become rich. Period.
It’s a mathematical certainty.
It’s no accident that my latest Special Report covers a company that just cracked RUBY-A’s genetic code. Such companies epitomize alpha!
In the case of RUBY-A, the patent holder is on track for gains as high as 1,369% in the weeks ahead.
In the hedge fund world, they call these “special situations.”
Think of George Soros and Jim Rogers, both of whom I regard as “True Alphas.” They pocketed $1 billion in a SINGLE DAY by shorting the British Pound. When Jim and I last chatted, he was in Korea, which is only a few hundred miles away from where he now lives, in Singapore. On the call, Jim warned me that North and South Korea are preparing to reunify. He also told me a brilliant way to invest alongside this fast-approaching geopolitical event. I swear I get smarter every time I chat with Jim.
Or Peter Schiff, who predicted the collapse of the housing market a full year before the crash. On our last call, Peter personally warned me about 1) the collapse of Bitcoin and 2) the rebound in the gold market. Within three weeks of our conversation, Peter was right about both. So typical of a True Alpha.
Or James Levin of Och-Ziff, who made $2 billion betting on a rally in structured debt products in 2012... a feat that earned him about $116 million last year in compensation.
Or John Paulsen, who executed what some believe is the greatest trade ever. He pulled down almost $4 billion in 2007, betting against the teetering mortgage market!
Heck, just recently, I sent my readers a Special Report that recommended buying shares of Cynosure (CYNO). The company’s tattoo-removing laser treatment had just been approved by the FDA to treat acne scars, as well. The move virtually doubled its market size, overnight. The stock is quickly up 50% off its October lows.
Investing alongside these types of “special situations” is the most explosive wealth-building strategy in finance. Period. It works in any market, too – up, down or sideways.
Thus, my research advisory, True Alpha, can help you crack the alpha code just as these gentlemen have done.
It all begins with my brand-new Special Report, The Blueprint for the $70 Billion RUBY-A Revolution, which stands ready to put $141,410 in your pocket.
But True Alpha transcends simply enjoying superlative investment returns.
True Alpha is a Mindset...
It’s a lifestyle.
It’s about skipping to the front of the line.
It’s about never waking up to alarm clocks or enduring a heavy morning commute.
It’s about enjoying the best job, the best house, and the best possessions, with himself/herself in charge.
For example, I don’t like sitting next to people on airplanes. Fortunately, I learned a secret that will help keep the seat next to you open.
I’ll share the secret with you inside the pages of True Alpha.
Here’s another secret.
When you drive a Porsche, people will chase you. Tailgate you. Stare at you at gas stations. I’ve even witnessed two gawkers crash their cars!
They do it because a Porsche symbolizes a dream lifestyle that most people can’t fathom ever enjoying themselves. But I’m living proof that it can happen.
When you sign up for True Alpha, I’ll share a secret that keeps cars off your bumper.
Now, most of you know my work by now. But for those of you who still don’t, I’m a “True Alpha,” through and through...
I’m Master’s educated and classically trained in finance.
I served as an analyst for a prestigious institution whose endowment, valued at $2.9 billion, is among the largest in the world.
I’ve also enjoyed tenure as the Senior Analyst to a Forbes Top 50 private corporation with $9.5 billion in revenue.
I’ve even moved millions of dollars around the capital markets, too, and hatched countless millions more into the economy.
In fact, since launching Wall Street Daily, it’s estimated that I’ve helped unlock $26 million in new investor wealth.
My brand-new Special Report could dramatically add to that total, and it’s available for immediate download.
But since the “RUBY-A Revolution” will reach far beyond the gains of a single company, I’ve put together an entire True Alpha Wealth-Building Package.
It’s designed so anyone can use it.
Just sign-up for a one-year subscription to Robert Williams’ True Alpha and I’ll rush you the entire package... for FREE.
The True Alpha Wealth-Building Package
Bonus #1: How to Unlock Alpha, Strategy Guide
Does wealth have a mathematical formula? That is, a code you can use to speed up your gains? You bet.
It’s called “alpha,” and it looks like this...
In this Strategy Guide, I’ll unlock the compounding power of alpha for you.
Remember the alpha portfolio I shared with you earlier? Well, adding one simple yet powerful dynamic – a dynamic missing from virtually every portfolio – could raise your alpha score. You could even turn a modest $1,000 investment into $51,257... or a $10,000 investment into $512,578.
Sadly, the alpha code is cleverly camouflaged from your view. It’s missing from virtually every portfolio. With it though, you can live rich, retire decades early, and lead a lifestyle truly befitting of a True Alpha.
My Strategy Guide is designed to be an easy, effective how-to manual for unlocking my True Alpha approach.
Bonus #2: The Blueprint for the $70 Billion RUBY-A Revolution
RUBY-A attacks the root cause of every non-communicable disease on Earth, including cancer, obesity, diabetes, heart disease, hypertension, high cholesterol. It even preempts the onset of Alzheimer’s, kidney disease, arthritis and depression.
A certain company’s patent guards the $70 billion market for RUBY-A. The patent could soon surpass Lipitor as the most valuable in history.
Lipitor turned a penny stock called Pfizer into one of the dominant companies in the S&P 500. This could be even bigger.
In fact, on the merits of rush-approval by the FDA and shockingly positive test results across the Deep South, the patent holder’s stock could make you $141,410 richer... beginning with the release of its first financial report.
The report could hit any day.
You’ll recall that a powerful, multi-billion-dollar agribusiness is quietly amassing shares, led by a man named “Entrepreneur of the Year” and “Best CEO of the Year” by Ernst & Young.
He could easily be the world’s latest billionaire when the first financial report hits.
Immediate action is highly recommended.
Bonus #3: The RUBY-A Aftershock Report
To call RUBY-A a miracle is an understatement, and not only from an investor’s standpoint.
Real-life success stories are already pouring in. Here’s one of thousands...
“During my uncle's four-month [cancer] cure period, he also lost 62 pounds of fat and flab, and Type 2 diabetes no longer registered.” – Dennis Sherman
But the financial aftershocks of RUBY-A’s arrival will reach far beyond one stock.
For example, when researchers cracked the genetic code of the RUBY-A-bearing plant, it hatched an opportunity for tobacco farmers to earn limitless profits.
According to Bloomberg, since the two leafs are handled similarly, the incredible demand for RUBY-A has farmers rushing to switch over their production.
Agribusinesses in warm states, like California, Georgia and North Carolina, are frantically making the switch as you read this.
My Aftershock Report will show you how to invest, accordingly.
Plus, I’ve identified a seed manufacturer whose scientific breakthrough could super-charge the growth of the RUBY-A bearing plant. Its stock is poised for a huge move in the days ahead.
Oh, and lest we forget about the iconic American food brand that just changed its formula to include RUBY-A.
Its product is consumed at the rate of more than 1.8 billion units per day.
As you read this report, the reformulated product is flying off store shelves. I isolated the one company whose stock will benefit the most.
Bonus #4: Alphacast, the HealthCare Apocalypse
The downstream metabolic effects of the toxin found in virtually every diet kills 36 million people every year.
In this video briefing, we dive into the story and reveal the very latest findings.
For example, according to a Credit Suisse report, this toxin places a $1 trillion-per-year burden on the U.S. healthcare system.
A whopping 75% of all U.S. healthcare dollars are spent treating non-communicable diseases... and EVERY PENNY can be traced back to this deadly food additive.
And now, Medicare stands on the brink of collapse.
Forbes Magazine warns that the program’s bankruptcy will occur NEXT YEAR.
Medicare’s own actuary, Richard Foster, also concedes that bankruptcy could arrive sooner than you think.
In my latest Alphacast, I’ll reveal an accounting gimmick that Congress has been using to keep the Medicare program artificially alive.
I’ll also reveal why Congress has been banking on the official arrival of Patent #20110X858867 to single handedly save the healthcare system from collapse.
Expect two other RUBY-A experts to be featured on my Alphacast, as well.
One is a well-versed expert on the patent protecting the $70 billion RUBY-A market.
The other has intimate knowledge of the patent holder’s extremely bullish financial condition.
Plus, when a situation demands it, I’ll hold another Alphacast to give you the full story.
Bonus #5: private Access to the “RUBY-A Revolution” Web Portal
Please understand that the RUBY-A Revolution isn’t some one-off health fad. Calling it such would do a disservice to every cancer, diabetes, obesity, and heart disease sufferer.
The official arrival of RUBY-A, along with the scientifically proven research concerning the nation’s deadly food toxin, represents an epochal event.
Life expectancy could increase from 79-years-old to 100-years-old.
The Revolution itself is a living, breathing entity. So in that regard, I built a Web Portal to archive the RUBY-A storyline as it evolves.
At this very moment, the Web Portal features a full-length documentary from a major news organization and a vignette produced by 60 Minutes...
The Portal also features supporting articles from Forbes, USA Today, The Wall Street Journal, Centers for Disease Control, World Health Organization, National Institute of Health, The Mayo Clinic, American Heart Association, American Cancer Society, The Arthritis Foundation, The Obesity Society, American Diabetes Association, National Institute of Mental Health, Johns Hopkins University, Harvard University and The Alzheimer’s Association.
Bonus #6: The Hardback Investor Series, featuring Jim Rogers
While supplies lasts, I’d like to mail you a FREE hardcopy of my favorite book: How I Cracked the Alpha Code by bestselling author and famed investor, Jim Rogers… and it’s a “must read” for any investor worth his salt.
If you haven’t heard of Jim, he’s the Co-Founder of the most successful hedge fund in history, The Quantum Fund.
The Fund is famous for “breaking” the Bank of England, and forcing it to devalue the pound.
The coup netted Jim and his partner, George Soros, a tidy $1 billion profit.
And get this…
Over one 10-year period, the Fund gained 4,200% while the S&P only advanced about 47%!
At the peak of the housing boom, Jim had most of his money out of equities with the following exceptions… he was short Citibank, all of the investment banks, the homebuilders, and Fannie Mae.
Brilliant, right?
Jim was born just a few blocks away from Wall Street Daily’s headquarters, and I get smarter every time I speak to him.
How I Cracked the Alpha Code is loaded to the gills with secrets… ones that every investor must know.
Perhaps if I reveal a few of my favorite threads in the book you’ll appreciate why I regard it as “mandatory reading” for any investor…
Chapter Four underscores the importance that short sellers play in global finance. "Short sellers are good for the market," says Jim. If you’ve ever wanted to “go short” but were too afraid, Jim identifies the common pitfalls, yet also reveals an ingenious way to profit from the market’s downside while also wonderfully limiting your risk.
Chapter Six discusses gold, and how it shot 600% higher when President Nixon closed the gold window… only to lose 50% of its value in the months that followed. It didn’t last, though. In fact, the temporary retreat of gold prices proved to be an epic buying opportunity. So with today’s gold prices down to $1,200/ounce (40% off the high), is this another historic buying opportunity?
Chapter Eight describes the perils facing the largest debtor nation in the history of the world, the United States. Chief among the problems is America’s savings rate of only 4%. Jim reveals six nations with savings rates above 30%, one of which is above 40%. Any rock-solid portfolio should have some strategic exposure to these countries.
Chapter 13, which is my personal favorite, reveals a once powerful currency secretly in trouble. As Jim says, “Any monopoly eventually destroys itself, and [this currency], in predictable fashion, is corroding from within.” You’ll likely be shocked at the currency in which Jim is speaking. I recommend opening positions alongside Jim’s prediction, ASAP.
Chapter 14 warns that nobody — not even the Pope — can cheat the laws of supply and demand. On such merits, Jim confidently assures us that commodity prices are headed higher… that is, thanks to the reality of worldwide supply shortages. But Jim is especially bullish on one particular commodity. Why he so convinced that this commodity will blast higher? “Because that’s the way the world has worked for thousands of years,” says Jim.
Plus, I’ll also send you my four-part interview with Jim. You won’t find these investment insights from Jim anywhere else on the planet.
I can vouch for that.
Fact is, not man people enjoy the luxury of speaking to someone of Jim’s ilk on the record. But I do.
I’m ready to mail you a free hardcopy of the book and the interviews, along with access to my entire True Alpha Wealth-Building Package.
You’ll get everything when you sign-up for Wall Street Daily’s flagship publication, Robert Williams’ True Alpha.
What Sets True Alphas Apart?
Well, we’re always on the move, going someplace, doing something.
When I most recently spoke to Jim Rogers, he was in Korea.
Peter Schiff was in Puerto Rico.
True Alphas have high energy, too. Even if that high energy is bottled up and bridled... you feel like it could bust out at any moment.
So how about you?
How long have you been pursuing the seemingly elusive goal of financial freedom? Like a dog chasing his own tail, it’s just out of the reach of most everyone.
How many books, workshops, brokers, and advisors have you sought?
How much money and time have you spent... and you’re still not financially independent?
Clearly, up until now, something has been amiss.
Well, you’re about to learn what that “something” is, and what you can do about it.
My research advisory, True Alpha, will break your habit of following outdated ideas about wealth, and wake you up to a new paradigm.
My latest Special Report concerning RUBY-A is a perfect example.
By adding one simple yet powerful dynamic to your portfolio – the alpha ingredient – you could turn a modest $1,000 investment into $51,257... or a $10,000 investment into $512,578.
You see, I’m in constant communication with scores of readers around the world. At a recent live training session that I hosted online, thousands attended. And based on that one massive event alone, I can tell you this...
Sadly, the alpha code is missing from virtually every portfolio.
With it, though, you can live rich, retire decades early, and lead a lifestyle truly befitting of a “True Alpha.”
But you don’t have to take my word for it. Take a look at what my readers are saying...
Your Reality Doesn’t Change Mine...
True Alpha distills the wisdom I’ve built up over the course of my life working alongside some of the wealthiest and most successful people on the planet.
I never sought to openly publish this information.
Until now, my Special Reports have been internal mechanisms... memos, if you will. I’d normally send them to my team of analysts.
They’re not intended to “cure” the ills of your portfolio... they’re merely to introduce you to the nontraditional ways that self-made billionaires and millionaires are making money.
Of course, I’m talking about Special Situations.
Thankfully, whether or not you believe in True Alpha doesn’t impact my own personal reality one iota. It only changes yours.
The information I present inside the pages of True Alpha will likely violate and contradict everything your financial planner and stockbroker has told you.
But I ask you, is your financial planner living a lifestyle like I’ve been describing?
So simply use whatever resonates with you.
For example, remember when the mega merger between Pfizer and AstraZeneca went bust.
A $1.13 Billion Payout in a Single Day...
What’s it like to be a True Alpha subscriber?
Well, when official news hit that the Pfizer/AstraZeneca merger was off the table, I rushed a Special Report to readers.
For the record, True Alphas LOVE it when mergers fail.
Here, I’ll paste the alert in below...
My "failed merger" strategy worked like a charm.
Soon thereafter, I learned that AstraZeneca shareholders would split a pot of money worth $1,134,000,000.
I even nailed the amount to the exact dollar!
Nontraditional? Yes.
Effective? Most definitely.
As a subscriber to Robert Williams’ True Alpha, you’ll receive no fewer than 10 Special Reports over the course of the year... the first of which is included in my massive RUBY-A Wealth-Building Package.
How to Take Advantage of this Opportunity Now...
So how much does it cost to join True Alpha?
I have to be honest with you. It’s not exactly cheap.
This kind of deep-dive research into Special Situations can run into the thousands of dollars per year – even the tens of thousands.
I myself subscribe to raw-data and research services costing that much. Heck, the Bloomberg terminal here in my office costs over $23,000 a year by itself.
If you’re serious about the market, well... then you understand the value of information.
Of course, I’m happy to pay a premium for truly game-changing information... and I can afford that luxury, thankfully.
But I also realize that not everyone enjoys similar luxuries.
Well, that’s part of the reason I launched True Alpha. It ties directly into my core belief – the belief that drives everything I do here.
In a nutshell, I believe: You can find huge opportunities in any market... and regular Americans deserve to know about them.
So True Alpha costs just $149 per year!
Considering that you can make 10 times your money from just one Special Situation, that’s a steal.
But here’s the thing. The opportunity with RUBY-A is so enormous that I want to remove ANY obstacles for you.
So for a limited time, here’s what I’m willing to do...
Simply agree to give Robert Williams’ True Alpha a try – today – and you won’t pay the normal price.
In fact, you won’t even pay half of that.
Instead, you’ll receive an entire year of True Alpha for just $39.
Considering how much you could pocket from my RUBY-A research alone, I consider the price more than fair.
What’s infinitely important to your financial cause now is this...
RUBY-A attacks the root cause of every non-communicable disease on Earth. It alone could increase our life expectancy from 79-years-old to 100-years-old.
A certain company’s patent guards the $70 billion market for RUBY-A.
The patent could soon surpass Lipitor as the most valuable in history. Lipitor turned penny stock, Pfizer, into one of the dominant companies in the S&P 500.
My True Alpha Wealth-Building Package shows you how to...
✓ Position yourself for a $141,410 payday as RUBY-A hits the market with full force.
✓ Position yourself for the RUBY-A aftershocks, which could be even more profitable than investment in the patent holder itself.
✓ You’ll get 10 additional Special Reports over the next 12 months.
✓ You’ll also get Jim Rogers’ latest book, How I Cracked the Alpha Code, along with his secret interviews, as a personal gift from me.
Please click here or call us toll-free at 866.444.1556 or 443.353.4337 and mention Priority Code: ETAOR179.
Your order will be processed immediately, and, minutes from now, you'll have access to my entire True Alpha Wealth-Building Package, including my latest Special Report with instructions and explanations on all of this.
Simply click here to go to our secure order form now.
I look forward to sharing the secrets I’ve learned working alongside some of the most successful True Alphas on the planet.
Ahead of the tape,
Robert Williams
Founder, Wall Street Daily
